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. In mouse female PGCs, expression of stimulated by retinoic acid gene 8 (Stra8) and meiosis are induced in response to retinoic acid provided from the mesonephroi [2] [3] [4] [5] . Given the widespread role of retinoic acid signalling during development 6, 7 , the molecular mechanisms that enable PGCs to express Stra8 and enter meiosis in a timely manner are unknown 2, 8 . Here we identify gene-dosage-dependent roles in PGC development for Ring1 and Rnf2, two central components of the Polycomb repressive complex 1 (PRC1) 9, 10 . Both paralogues are essential for PGC development between days 10.5 and 11.5 of gestation. Rnf2 is subsequently required in female PGCs to maintain high levels of Oct4 (also known as Pou5f1) and Nanog expression 11 , and to prevent premature induction of meiotic gene expression and entry into meiotic prophase. Chemical inhibition of retinoic acid signalling partially suppresses precocious Oct4 downregulation and Stra8 activation in Rnf2-deficient female PGCs. Chromatin immunoprecipitation analyses show that Stra8 is a direct target of PRC1 and PRC2 in PGCs. These data demonstrate the importance of PRC1 gene dosage in PGC development and in coordinating the timing of sex differentiation of female PGCs by antagonizing extrinsic retinoic acid signalling.
In mammalian somatic cells, PRC1 and PRC2 proteins are transcriptional repressors that function in large multiprotein complexes and that modify chromatin by mono-ubiquitinating histone H2A at lysine 119 (H2AK119u1) and trimethylating histone H3 at lysine 27 (H3K27me3), respectively 9, 12 . At day 12.5 of embryonic development (E12.5), in PGCs marked by Cdh1 (E-cadherin) staining 13 , we observed nuclear localization of PRC1 components Rnf2 (also known as Ring1B), Mel18 (also known as Pcgf2) and Rybp ( Fig. 1a and Supplementary Fig. 1 ) as well as a robust H2AK119u1 signal, suggesting the presence of catalytically active PRC1 complexes (Fig. 1a) address the function of PRC1 in PGC development ( Supplementary  Fig. 2 Figs 3 and 6a ). This strategy resulted in ,90% deletion efficiency at E11.5 ( Supplementary Fig. 4 ). At E12.5, Rnf2, Mel18, Rybp and H2AK119u1 were lost in PGCs of Rnf2 cko embryos but not of Rnf2 fl/D embryos, carrying one functional allele, indicating that complex stability and catalytic activity of PRC1 is regulated by Rnf2 in PGCs at E12.5 ( Fig. 1a and Supplementary Figs 1 and  4) . By contrast, Ezh2 and H3K27me3 levels were similar in Rnf2 cko versus control PGCs, suggesting globally unaltered PRC2 function in Rnf2 cko PGCs ( Supplementary Fig. 5 ). To study the fate of Rnf2-deficient PGCs, we analysed expression of the pluripotency and germ cell marker Oct4 in whole gonads of E10.5-E13.5 embryos (Fig. 1b and Supplementary Fig. 2 ). We observed a strong reduction of Oct4-positive PGCs, specifically in female Rnf2 cko embryos but not in male Rnf2 cko or control embryos, starting around E12.5 of gestation (Fig. 1b, c) . By contrast, double deficiency of Ring1 and Rnf2 caused a strong reduction of Oct4 1 PGCs by E11.5 in both sexes ( Supplementary Fig. 6b, c) , indicating an essential role for PRC1 in PGCs after their migration into the embryonic gonad ( Supplementary Fig. 2) 
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.
To further dissect the role of Rnf2 in regulating Oct4 expression versus PGC development, we assessed co-expression of Oct4 and Rnf2 at E12.5 in Cdh1
1 PGCs in Rnf2 cko embryos (Fig. 1d ). The number of PGCs lacking detectable Rnf2 protein was strongly reduced in female but not male gonads, despite the fact that gonads of both sexes harboured comparable numbers of Rnf2-deficient PGCs at E12.0 (Supplementary Fig. 4a , and data not shown). We further observed a pronounced downregulation of Oct4 protein in female and some male Rnf2-deficient PGCs (Fig. 1d) . These data indicate that Rnf2 contributes to maintaining Oct4 expression, particularly in female PGCs, beginning between E12.0 and E12.5.
We subsequently investigated the mechanism underlying the reduction in female Rnf2-deficient PGCs. We failed to observe increased levels of apoptosis or major changes in cell cycle progression (data not shown). To study changes in gene expression, we introduced a green fluorescent protein (GFP) transgene driven by the promoter of Oct4 lacking the proximal enhancer (Oct4(DPE)-GFP)) 18 into the Rnf2 cko strain and isolated pure populations of PGCs by fluorescence-activated cell sorting (FACS) (Fig. 1e) . By quantitative reverse transcriptase PCR (qRT-PCR), we barely detected any Rnf2 transcripts in isolated Rnf2 cko PGCs, confirming efficient deletion of the Rnf2 fl allele by Tnap-cre ( Fig. 1f ; see also Supplementary Fig. 4 ). Hence, we subsequently refer to PGCs from Rnf2 cko embryos as Rnf2
We also noticed significant reductions in GFP intensities in Rnf2 D PGCs isolated from male and female E11.5 and E12.5 embryos compared to controls ( Fig. 1e) , suggesting decreased Oct4(DPE) promoter activity in these cells. qRT-PCR analysis showed significantly reduced Oct4 and Nanog expression in female GFP-positive Rnf2 D PGCs at E11.5 and E12.5 ( Fig. 1f and data not shown). Thus, Rnf2 is required for maintaining the expression of pluripotency factors in PGCs.
We next analysed genome-wide expression in purified PGCs. The number of misregulated genes in female compared to male Rnf2 D PGCs at E12.5 was 12-fold higher ( Fig. 2a Fig. 8 and Supplementary Table 2 ). These data indicate that although Ring1 expression is sufficient to safeguard global repression of canonical Polycomb target genes in PGCs, Rnf2 is required in female E12.5 PGCs for repression of genes driving meiosis.
At E11.5, gonads still possess the potential to develop into either ovaries or testes, but are committed to a sex-specific differentiation process 2 days later. To relate aberrant expression in Rnf2 D PGCs to changes occurring during normal PGC differentiation, we profiled expression in Rnf2 1 PGCs isolated between E11.5 and E13.5. In this developmental period, sixfold more genes were upregulated in female (810) than in male (132) Rnf2 1 PGCs, with an additional 196 genes being upregulated in both sexes, suggesting the activation of femaleand male-specific 'PGC-differentiation programs' (PDPs) (Fig. 2b) . Among genes upregulated in E12.5 female Rnf2 D PGCs, 223 (43%) were found to be part of the female PDP (Fig. 2b and Supplementary  Fig. 7b ) (P value 2.67 3 10
2159
; geometric test), being activated about 1 day ahead compared to those in Rnf2 1 PGCs (Fig. 2c ). 
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We next identified that 24 out of 119 genes annotated with the Gene Ontology term 'meiosis' (GO:0007126) were part of the female PDP, probably reflecting activation of an 'early meiosis program' (Fig. 2d) . Among these 24 genes, 10 were precociously upregulated in female Rnf2 D PGCs, including Stra8, required for meiotic initiation 5 , and others such as Rec8, Sycp3, and Hormad2, which have key functions in cohesion, chromosome synapsis and recombination [20] [21] [22] . Using qRT-PCR, we measured high Stra8, Rec8 and Sycp3 messenger RNA levels at E13.5 in female Rnf2
1 PGCs (Fig. 3a) . (Fig. 3a) . Immunofluorescence analyses revealed strong Stra8 nuclear localization by E12.5 in PGCs of Rnf2 cko gonads, whereas the protein only started to accumulate in control PGCs at E13.5 ( Fig. 3b and Supplementary Fig. 7c ). For Sycp3, we observed focal nuclear staining at E13.5 and synaptonemal complex staining at E14.5 in Rnf2 D germ cells, whereas only axial elements of meiotic chromosomes were visible in Rnf2 1 germ cells at E14.5 (Fig. 3c, d , data not shown). These data indicate that precocious transcriptional activation of Stra8 and other PGC differentiation and meiosis genes in female Rnf2 D PGCs induces these cells to prematurely stop proliferation and enter into meiotic prophase, hence accounting for the lower number of female Rnf2 D PGCs at E12.5. We also measured increased expression of genes functioning in retinoic acid metabolism, such as Aldh1a2, Crabp1 and Crabp2 in female Rnf2 D PGCs at E11.5 and 12.5 ( Supplementary Fig. 7d and data not shown), probably enhancing retinoic acid signalling and meiotic entry in a feed-forward manner 23 . We next wanted to find out why Stra8 transcription is abnormally activated only in female Rnf2 D PGCs. In male gonads, retinoic-acidmediated induction of Stra8 is counteracted by the somatically expressed retinoid-degrading enzyme Cyp26b1 and by the Fgf9 signalling pathway (Supplementary Fig. 2) 3, 4, 24 . PRC1 may therefore not be required to suppress Stra8 expression in males. To study this possibility, we aimed to overcome the antagonizing activity of Cyp26b1 and cultured E11.5 genital ridges for 24 h in the presence of all-trans retinoic acid (ATRA) 3, 4 . ATRA increased Stra8 expression in isolated Rnf2 1 PGCs of both sexes to levels comparable with what we measured in female Rnf2 D PGCs treated with vehicle (Fig. 4a) . Intriguingly, ATRA additionally enhanced Stra8 expression in male as in female Rnf2 D PGCs to .fivefold higher levels compared to Rnf2 1 PGCs (Fig. 4a) , indicating that PRC1 effectively suppresses retinoic-acid-induced Stra8 activation in PGCs of both sexes. We observed comparable responses for Rec8 and Sycp3 expression (Fig. 4a) . By contrast, Stra8 activation was completely suppressed in all genotypes by treatment with Win-18446 (N,N9-octamethylenebis(dichloroacetamide)), an inhibitor of the retinoic acid biogenesis pathway 25 (Fig. 4a) . Likewise, 2-day in vivo exposure of PGCs to Win-18446 in developing embryos suppressed premature Stra8 protein expression ( Supplementary Fig. 9a, b) . In addition, numbers of Oct4-expressing PGCs in Rnf2 cko gonads were significantly increased upon treatment in vitro and in vivo with Win-18446 ( Fig. 4b and Supplementary Fig. 9c, d) . These results indicate that sensitization of PGCs to retinoic acid signalling by Rnf2 deficiency contributes to precocious exit from the PGC state and activation of the meiotic program in female gonads.
Subsequently, most Rnf2 D PGCs were unable to complete meiosis and to develop into mature oocytes ( Supplementary Fig. 10 ), possibly as a consequence of the precocious entry into meiosis that may eventually impair, perhaps in concert with other aberrant changes in gene expression (Fig. 2b) , the execution of the natural female PDP and oogenesis. Alternatively, PRC1 may exert a separate essential function later during meiotic progression.
Finally, we performed a micro-chromatin immunoprecipitation (mChIP) assay on isolated Rnf2 1 PGCs. At E11.5, the Stra8 promoter was strongly enriched with PRC2-mediated H3K27me3 and with 
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H3K4me3, indicative of a Polycomb repressed, yet potentially transcriptionally primed, chromatin state. During subsequent stages, we noticed a progressive decrease in H3K27me3 levels in female PGCs consistent with Stra8 transcriptional activation, whereas the promoter remained bivalent in male PGCs (Fig. 4c) . By contrast, the Hoxa9 promoter was bivalent in all conditions ( Supplementary Fig. 11 ). Likewise, we detected Rnf2 association with the Stra8 promoter at E11.5 and E12.5 PGCs and a significant decrease in Rnf2 occupancy in female but not male PGCs at E13.5. Together, these experiments suggest that Stra8 is directly regulated by PRC2 and PRC1 in PGCs of both sexes.
In summary, we identified an essential role for PRC1 in PGC development between E10.5 and E11.5. Later, between E11.5 and E13.5, Rnf2 effectively modulates the sensitivity of PGCs to retinoicacid-mediated induction of meiosis by directly controlling the competence of Stra8 and probably of other meiotic genes for transcriptional activation. Like the proposed role of Cbx2 in temporal co-linearity of Hox gene activation 26 , we speculate that PRC1 maintains repression of Stra8 and other genes of the PGC differentiation and early meiosis programs until retinoic acid signalling has reached a certain threshold (Fig. 4d) . In addition, PRC1 regulates the expression of pluripotency genes in PGCs, possibly indirectly by suppressing transcription of negative regulators. Impairing PRC1 function in these parallel pathways probably leads to a synergistic effect, thereby promoting premature transition from proliferation into meiosis.
METHODS SUMMARY
Embryos were obtained by timed matings, by scoring noon of the day after mating as E0.5. Genital ridges were cultured in drops of Dulbecco's minimal eagle medium supplemented with 10% fetal calf serum at 37 uC with 5% CO 2 in air. For expression profiling, we collected in triplicate 500 PGCs per embryo by fluorescence-activated cell sorting and processed, hybridized to Affymetrix Mouse Gene 1.0 arrays and analysed as described previously 10 . Gene Ontology terms were obtained using GOstat (http://gostat.wehi.edu.au). mChIP was performed as described previously 27 .
Full Methods and any associated references are available in the online version of the paper. 14 with the Tnap-cre transgene allele as illustrated in Supplementary Fig. 3 . Introduction of the Ring1 mutation 17 is illustrated in Supplementary Fig. 6a . For PGC isolation, embryos were sired by fathers that were homozygous for the Oct4(DPE)-GFP transgene. Mice were maintained on a mixed background of 129/Sv and C57BL/6J. Embryos were obtained by timed matings, by scoring noon of the day following mating as 0.5 embryonic day of development (E0.5). The genotype of embryos was determined by PCR as described previously 14 . Sex of gonads was determined by PCR for Ubex1 using the following primers: forward, 59-TGGTCTGGACCCAAACGCTG TCCACA-39; reverse, 59-GGCAGCAGCCATCACATAATCCAGATG-39. All experiments were performed in accordance with the Swiss Animal Protection laws and institutional guidelines. Antibodies. For immunofluorescence analyses, the following primary and secondary antibodies were used: polyclonal anti-Oct4 (sc-8628, 1:150), monoclonal anti-Rnf2 (gift from H. Koseki, 1:400) 28 , monoclonal anti-E-cadherin (Invitrogen, 1:250), polyclonal anti-Stra8 (rabbit, gift from M. Griswold, 1:1,000) 29 , polyclonal anti-Sycp3 (rabbit, gift from C. Heyting, 1:500) 30 , polyclonal anti-Mel18 (sc-10774, 1:50), polyclonal anti-Rybp (1:400) 31 , monoclonal anti-H2AK119u1 (Cell signaling, 1:500), polyclonal anti-H3K27me3 (gift from T. Jenuwein, 1:500) 32 , monoclonal anti-Ezh2 (Novocastra, 1:200), anti-goat IgG-Alexa 488, anti-rabbit IgG-Alexa 488, anti-mouse IgG-Alexa 555 and anti-rat Cy5. For ChIP analysis, anti-H3K4me3 (Millipore, 17-614), anti-H3K27me3 (Millipore, 07-449) and antiRnf2 (Active motif, 39663) were used. Immunofluorescence. For whole-mount stainings, dissected gonads with mesonephroi were fixed for 15 min in 3% paraformaldehyde in PBS (pH 7.4) and permeabilized with 0.5% Triton X-100 in PBS for 20 min on ice. Fixed embryos were blocked overnight at 4 uC in PBS containing 0.1% Triton X-100, 10% BSA and 5% normal donkey serum, and were then incubated with primary antibodies in blocking solution overnight at 4 uC. Gonads were washed three times for 1 h in PBS containing 0.1% Triton X-100 and 2% BSA before application of secondary antibodies. For detection, secondary antibodies were diluted 1:500 in blocking solution and gonads were incubated overnight at 4 uC followed by three washing steps for 1 h in PBS with 0.1% Triton X-100. Gonads were stained briefly with DAPI and mounted in Vectashield (Vector). For gonadal section stainings, the posterior part of embryos or gonads with mesonephroi were frozen in Tissue-Tek Optimal Cutting Temperature (OCT) compound (Sakura Finetek) on dry ice. Alternatively, the materials were fixed with 3% paraformaldehyde in PBS (pH 7.4) for 10 min, soaked in 30% sucrose solution overnight and embedded in OCT compound. Twelve-micron-thick cryo-sections were cut from frozen blocks with Microm HM355S. Cryo-sections were fixed with 3% paraformaldehyde for 10 min at room temperature (about 20 uC), permeabilized in 0.5% Triton X-100 in PBS for 4 min at 4 uC and blocked for 30 min in PBS containing 1% BSA at room temperature. Sections were incubated with primary antibodies in blocking solution overnight at 4 uC and subsequently washed three times for 10 min in PBS with 0.05% Tween-20. Incubation of secondary antibodies was done in the blocking solution for 1 h at room temperature. Microscopy and image analysis. Immunofluorescence stainings of gonads were analysed using the Zeiss LSM 700 confocal microscope. For whole-mount gonads, images were acquired by using a tile function with a z-series of 1-mm slices in ZEN software and whole image was reconstructed using the XUV-tools software. We counted the number of Oct4-positive cells using a spot function in Imaris (Bitplane) software. Isolation of PGCs expressing the Oct4(DPE)-GFP transgene by FACS. Dissected gonads were enzymatically disrupted using 0.025% trypsin at 37 uC for 8 min. Trypsin activity was inhibited by adding fetal calf serum in Hank's buffer salt solution without phenol red. Gonads were dispersed by pipetting and subjected to FACS. Embryos were processed individually for expression analysis. PGCs isolated from several embryos were pooled for ChIP analysis. qRT-PCR. Total RNA was extracted from isolated PGCs or surrounding somatic cells from individual embryos using the PicoPure RNA Isolation Kit (KIT0202) according to the manufacturer's instructions (Stratagene) with the addition of 100 ng Escherichia coli ribosomal RNA as carrier. RT-PCR was performed using SuperScript III Reverse Transcriptase (Invitrogen) according to the manufacturer's protocol. qPCR reactions were performed with complementary DNA corresponding to 20 cells using the SYBR Green PCR Master Mix (Applied Biosystem) in an ABI Prism 7000 Real time PCR machine. All qPCR measurements were normalized to the endogenous expression level of Tbp. We performed qRT-PCR analyses on multiple pairs of Rnf2 cko and control littermates. Data in figures present technical replicates for pairs of genotypes. Primers used were as follows: Rnf2 (forward, 59-TTAGAAGTGGCAACAAAGAGTG-39; reverse, 59-CGCTTCATACTCATCACGAC-39), Oct4 (forward, 59-GATGCTGTGAGCCA
